John Ballantyne

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Fargo,, ND
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Ballantyne

Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
2,743,591
Estimated value
$85,051,321
Report date
12 Mar 2025
Price
$31.00
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
4,126
Estimated value
$127,906
Report date
26 Mar 2025
Price
$31.00
Ownership
Direct
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Series A Common Warrant
Shares / value
132,036
Estimated value
Report date
14 Nov 2024
Price
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Underlying class
Common Stock, par value $0.001 per share
Underlying amount
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Warrants to Purchase Common Stock
Shares / value
59,260
Estimated value
Report date
30 Jul 2024
Price
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Underlying class
Common Stock, par value $0.001 per share
Underlying amount
Form 4 holding Director, 10%+ Owner

Glucotrack, Inc.

Security class
Series B Common Warrant
Shares / value
0
Estimated value
Report date
12 Mar 2025
Price
Ownership
John A. Ballantyne Rev Trust 08/01/2017
Underlying class
Common Stock, par value $0.001 per share
Underlying amount

Insider Reports Filed by John Ballantyne

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .